Contact
Please use this form to send email to PR contact of this press release:
Inclusig (Ponatinib): Drug Safety Communication - Increased Reports Of Serious Blood Clots In Arteries And Veins
TO:
Please use this form to send email to PR contact of this press release:
Inclusig (Ponatinib): Drug Safety Communication - Increased Reports Of Serious Blood Clots In Arteries And Veins
TO: